The current valuation score of Cardiff Oncology Inc is 6.11, ranking 358 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.91, which is -44.98% below the recent high of -1.05 and -242.33% above the recent low of -6.54.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.